Power Solutions (PSIX) Insider Files Form 144 for 10,000-Share Sale

Rhea-AI Filing Summary

Power Solutions International (PSIX) notice reports a proposed sale of 10,000 shares of Common Stock through Merrill Lynch on Nasdaq with an aggregate market value of $912,600 and an approximate sale date of 08/25/2025. The filing lists total shares outstanding as 23,029,846. The securities were acquired as compensatory grants: 5,000 shares on 07/13/2018 and 5,000 shares on 07/10/2024. The filing also reports a sale during the past three months: Frank Simpkins sold 5,000 shares on 08/12/2025 for $474,274. The notice includes the signers representation that they are not aware of undisclosed material adverse information about the issuer.

Positive

• Filing discloses a proposed sale of 10,000 PSIX shares totaling $912,600, demonstrating regulatory compliance
• Source of the shares is specified as compensatory grants (07/13/2018 and 07/10/2024), providing clear acquisition history
• Recent sale of 5,000 shares on 08/12/2025 for $474,274 is reported, enhancing transaction transparency

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sale notice for 10,000 PSIX shares filed; transaction size is disclosed and appears routine.

The Form 144 shows a proposed sale of 10,000 shares with an aggregate market value of $912,600 to be executed through Merrill Lynch on Nasdaq. The shares were granted as compensation in 2018 and 2024, and a prior sale of 5,000 shares on 08/12/2025 for $474,274 is disclosed. From a trading-impact perspective, the filing documents required disclosure and provides clear dates, acquisition nature, and proceeds for recent sales. No earnings or operational data are included in the filing to alter company valuation directly.

Corporate Governance Expert

TL;DR: Filing meets disclosure obligations; it documents compensatory-origin shares and recent sale activity.

The notice identifies the securities as compensatory grants and includes the mandatory attestation regarding material nonpublic information. This transparency aligns with governance and insider-trading compliance practices. The record of a recent sale within the past three months is provided, which helps maintain market disclosure integrity. The form does not provide any information about role, timing rationale, or a trading plan adoption date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 2 Pickwick Plaza, 4th Floor Greenwich CT 06830	10000	912600.00	23029846	08/25/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/13/2018	Compensatory grant from issuer	N/A			5000	07/13/2018	Compensatory grant from issuer
Common Stock	07/10/2024	Compensatory grant from issuer	N/A			5000	07/10/2024	Compensatory grant from issuer

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Frank Simpkins 201 Mittel Drive Wood Dale IL 60191	Common Stock	08/12/2025	5000	474274.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PSIX Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 10,000 shares of PSIX common stock through Merrill Lynch on Nasdaq with an aggregate market value of $912,600 and an approximate sale date of 08/25/2025.

How were the shares being sold acquired according to the filing?

The securities were acquired as compensatory grants: 5,000 shares on 07/13/2018 and 5,000 shares on 07/10/2024.

Did the filer report any securities sold in the past three months?

Yes. The filing reports that Frank Simpkins sold 5,000 shares on 08/12/2025 for $474,274.

Through which broker will the proposed PSIX sale be executed?

The proposed sale is listed to be executed through Merrill Lynch, 2 Pickwick Plaza, Greenwich, CT on the Nasdaq exchange.

How many PSIX shares are outstanding per the Form 144?

The filing lists 23,029,846 shares outstanding.

Does the filer state they possess any undisclosed material information?

The signer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.